Taysha Gene Therapies Inc Live Stock Price Today, Share Analysis and Chart

Name: Taysha Gene Therapies Inc: Is Infosys Ltd. worth buying?
Item: Taysha Gene Therapies Inc
Rating: 1.83300
Author: Trendlyne DVM scores

about

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large...

2.88 -0.11 (-3.68%)

174.29% Gain from 52W Low

1.1M

XNAS Volume

XNAS 19 Sep, 2025 3:29 PM (EDT)

Not Eligible

Expensive Valuation

9.5 / 100

Technically Moderately Bullish

63.8 / 100

1Yr Price target upside is 201%

12 analysts

Taysha Gene Therapies Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Taysha Gene Therapies Inc Live Stock Price Today, Share Analysis and Chart

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large...

174.29% Gain from 52W Low

SWOT Analysis

Taysha Gene Therapies Inc Live Price Chart